Mobile phones in cryptogenic strOke patients Bringing sIngle Lead ECGs to detect Atrial Fibrillation

Mobile phones in cryptogenic strOke patients Bringing sIngle Lead ECGs to detect Atrial Fibrillation - MOBILE-AF trial

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON42745

Enrollment

180

Registered

2016-04-11

Start date

2016-07-29

Completion date

Unknown

Last updated

2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atrial fibrillation

Interventions

After inclusion, patients will be randomized to either the AliveCor or a 7-Day Holter Monitor.

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patient with cryptogenic stroke Patient with cryptogenic TIA

Exclusion criteria

Exclusion criteria: - Known etiology of TIA or stroke - Myocardial infarction

Design outcomes

Primary

Measure	Time frame
The main endpoint will be the percentage of detected atrial fibrillation in both the AliveCor group and the 7-Day Holter group after one year.	—

Secondary

Measure	Time frame
- Pro-BNP levels in all patients within 24 hours after cryptogenic stroke - Percentages of atrial ectopy detected on the 7-day Holter monitor - Left atrial diameter and volume - Recurrent stroke - Major bleeding	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)